XML 28 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions
3 Months Ended
Mar. 31, 2018
Related Party Transactions [Abstract]  
Related Party Transactions

11.

Related Party Transactions

As described in Note 8, in January 2016 the Company entered into a License Agreement with NHS for the development and commercialization of certain product candidates in development for the treatment and management of CDI and IBD, including UC and Crohn’s disease. NHS is a related party since NHS is an affiliate of Nestlé Health Science, one of the Company’s significant stockholders. During the three months ended March 31, 2018 and 2017, the Company recognized $3,766 and $3,015 of related party revenue associated with the License Agreement. As of March 31, 2018, there was $120,192 of deferred revenue related to the License Agreement, which is classified as current or non-current in the consolidated balance sheets. The Company has made no payments to NHS during the three months ended March 31, 2018. There is $175 due from NHS as of March 31, 2018 for the reimbursement of development costs, which is classified as other current assets in the Company’s consolidated balance sheet.